간세포암의 근치적 절제술 후 실제 5년 생존율
저자
발행기관
학술지명
한국간담췌외과학회지(Korean journal of hepato-biliary-pancreatic surgery)
권호사항
발행연도
2005
작성언어
Korean
KDC
514
자료형태
학술저널
수록면
140-144(5쪽)
KCI 피인용횟수
0
제공처
Purpose: After curative resection for hepatocellular carcinoma
(HCC), the five-year survival rate ranges between 30∼
50%; however, this might be different from the actual survival
rate. The actual 5-year survival rate and prognostic factors
following curative resection for HCC were analyzed.
Methods: A retrospective analysis was performed on 63 HCC
patients, who had undergone curative resection, between
1998 and 1999.
Results: A total of 63 cases, including 53 men and 10
women, were reviewed. The median age was 49 years old.
Pathologic T stage I, II, III and IV were observed in 1, 17,
38 and 7 cases, respectively. The actual 1-, 3- and 5-year
survival rates were 85.7, 69.8 and 57.0%, respectively, with
a median survival time of 58 months. The actual 1-, 3- and
5-year disease free survival rates were 68.1, 51.9 and 50.2%,
respectively, with a median disease free survival time of 46
months. Thirty-one patients had recurrence, mostly within one
year (65%), indicating a poor survival rate, with an actual
5-year survival rate of 5%. A satellite nodule, the pT stage,
recurrence of tumor, time to recurrence (within one year), and
presence of extrahepatic metastasis were found to be prognostic
factors influencing the survival rate of HCC patients.
However, microvessel invasion caused a difference in the
survival rate, but without statistical significance (p=0.08). A
satellite nodule, microvessel invasion and the pT stage were
found to be factors influencing the disease free survival rateof HCC patients. No statistically related factors, with the exception
of the pT stage, were found in a multivariate analysis.
Conclusion: The actual 5-year survival and disease free
survival rates were 57.0 and 50.2%, respectively. The time
to recurrence and pT stage were found to be factors influencing
the survival rate of patients with a hepatocellular
carcinoma. Further advanced studies will have to be carried
out for the active treatment of HCC cases with a pT stage
III or IV to reduce recurrence.
Purpose: After curative resection for hepatocellular carcinoma
(HCC), the five-year survival rate ranges between 30∼
50%; however, this might be different from the actual survival
rate. The actual 5-year survival rate and prognostic factors
following curative resection for HCC were analyzed.
Methods: A retrospective analysis was performed on 63 HCC
patients, who had undergone curative resection, between
1998 and 1999.
Results: A total of 63 cases, including 53 men and 10
women, were reviewed. The median age was 49 years old.
Pathologic T stage I, II, III and IV were observed in 1, 17,
38 and 7 cases, respectively. The actual 1-, 3- and 5-year
survival rates were 85.7, 69.8 and 57.0%, respectively, with
a median survival time of 58 months. The actual 1-, 3- and
5-year disease free survival rates were 68.1, 51.9 and 50.2%,
respectively, with a median disease free survival time of 46
months. Thirty-one patients had recurrence, mostly within one
year (65%), indicating a poor survival rate, with an actual
5-year survival rate of 5%. A satellite nodule, the pT stage,
recurrence of tumor, time to recurrence (within one year), and
presence of extrahepatic metastasis were found to be prognostic
factors influencing the survival rate of HCC patients.
However, microvessel invasion caused a difference in the
survival rate, but without statistical significance (p=0.08). A
satellite nodule, microvessel invasion and the pT stage were
found to be factors influencing the disease free survival rateof HCC patients. No statistically related factors, with the exception
of the pT stage, were found in a multivariate analysis.
Conclusion: The actual 5-year survival and disease free
survival rates were 57.0 and 50.2%, respectively. The time
to recurrence and pT stage were found to be factors influencing
the survival rate of patients with a hepatocellular
carcinoma. Further advanced studies will have to be carried
out for the active treatment of HCC cases with a pT stage
III or IV to reduce recurrence.
분석정보
서지정보 내보내기(Export)
닫기소장기관 정보
닫기권호소장정보
닫기오류접수
닫기오류 접수 확인
닫기음성서비스 신청
닫기음성서비스 신청 확인
닫기이용약관
닫기학술연구정보서비스 이용약관 (2017년 1월 1일 ~ 현재 적용)
학술연구정보서비스(이하 RISS)는 정보주체의 자유와 권리 보호를 위해 「개인정보 보호법」 및 관계 법령이 정한 바를 준수하여, 적법하게 개인정보를 처리하고 안전하게 관리하고 있습니다. 이에 「개인정보 보호법」 제30조에 따라 정보주체에게 개인정보 처리에 관한 절차 및 기준을 안내하고, 이와 관련한 고충을 신속하고 원활하게 처리할 수 있도록 하기 위하여 다음과 같이 개인정보 처리방침을 수립·공개합니다.
주요 개인정보 처리 표시(라벨링)
목 차
3년
또는 회원탈퇴시까지5년
(「전자상거래 등에서의 소비자보호에 관한3년
(「전자상거래 등에서의 소비자보호에 관한2년
이상(개인정보보호위원회 : 개인정보의 안전성 확보조치 기준)개인정보파일의 명칭 | 운영근거 / 처리목적 | 개인정보파일에 기록되는 개인정보의 항목 | 보유기간 | |
---|---|---|---|---|
학술연구정보서비스 이용자 가입정보 파일 | 한국교육학술정보원법 | 필수 | ID, 비밀번호, 성명, 생년월일, 신분(직업구분), 이메일, 소속분야, 웹진메일 수신동의 여부 | 3년 또는 탈퇴시 |
선택 | 소속기관명, 소속도서관명, 학과/부서명, 학번/직원번호, 휴대전화, 주소 |
구분 | 담당자 | 연락처 |
---|---|---|
KERIS 개인정보 보호책임자 | 정보보호본부 김태우 | - 이메일 : lsy@keris.or.kr - 전화번호 : 053-714-0439 - 팩스번호 : 053-714-0195 |
KERIS 개인정보 보호담당자 | 개인정보보호부 이상엽 | |
RISS 개인정보 보호책임자 | 대학학술본부 장금연 | - 이메일 : giltizen@keris.or.kr - 전화번호 : 053-714-0149 - 팩스번호 : 053-714-0194 |
RISS 개인정보 보호담당자 | 학술진흥부 길원진 |
자동로그아웃 안내
닫기인증오류 안내
닫기귀하께서는 휴면계정 전환 후 1년동안 회원정보 수집 및 이용에 대한
재동의를 하지 않으신 관계로 개인정보가 삭제되었습니다.
(참조 : RISS 이용약관 및 개인정보처리방침)
신규회원으로 가입하여 이용 부탁 드리며, 추가 문의는 고객센터로 연락 바랍니다.
- 기존 아이디 재사용 불가
휴면계정 안내
RISS는 [표준개인정보 보호지침]에 따라 2년을 주기로 개인정보 수집·이용에 관하여 (재)동의를 받고 있으며, (재)동의를 하지 않을 경우, 휴면계정으로 전환됩니다.
(※ 휴면계정은 원문이용 및 복사/대출 서비스를 이용할 수 없습니다.)
휴면계정으로 전환된 후 1년간 회원정보 수집·이용에 대한 재동의를 하지 않을 경우, RISS에서 자동탈퇴 및 개인정보가 삭제처리 됩니다.
고객센터 1599-3122
ARS번호+1번(회원가입 및 정보수정)